The maker of Tylenol, a spinoff of J&J, has underperformed. But Kenvue could bounce back thanks to help from activist ...

Shares of Kenvue Inc. KVUE slipped 1.29% to $21.49 Tuesday, on what proved to be an all-around poor trading session for the ...

Shares of Kenvue Inc. KVUE slipped 2.51% to $21.77 Monday, on what proved to be an all-around grim trading session for the ...

Since President Donald Trump announced new tariff policies on April 2, the S&P 500 and Nasdaq Composite each declined about ...

Redburn Atlantic initiated coverage of Kenvue (KVUE) with a Neutral rating and $23.50 price target The company’s first two years as a public ...

Kenvue Inc, a United States-based consumer health company, will deploy more resources to support medical associations and ...

Kenvue Inc, a United States-based consumer health company, will deploy more resources to support medical associations and ...

Fintel reports that on April 10, 2025, Redburn Atlantic initiated coverage of Kenvue (NYSE:KVUE) with a Neutral recommendation. Analyst Price Forecast Suggests 13.39% Upside As of April 2, 2025, the ...

We recently published a list of 12 Best FMCG Stocks to Buy According to Billionaires. In this article, we are going to take a ...

Bullish option flow detected in Kenvue ( KVUE) Inc with 22,105 calls trading, 2x expected, and implied vol increasing almost 8 points to 65.75%. Sep-25 24 calls and Sep-25 23 calls are the most active ...

Detailed price information for Kenvue Inc (KVUE-N) from The Globe and Mail including charting and trades.

Kenvue Inc (NYSE:KVUE) shares are trading higher Monday following reports that a New-York based hedge fund has amassed a stake and is pushing for changes.